Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Gut Microbes Combine To Cause Colon Cancer, Study Suggests

    Feb 5, 2018, 10:36 AM by Michael Croft
    The New York Times | Two types of bacteria common in the gut may accelerate the growth of tumors, suggesting new possibilities for diagnosis and prevention.
    Full story
  • Despite Doubters, Moderna Raises $500 Million, Is Now Worth $7 Billion

    Feb 2, 2018, 11:32 AM by Michael Croft
    Forbes | Moderna Therapeutics, a biotechnology firm that is developing drugs that work on a genetic messaging system that is essentially to all living cells, has raised $500 million from a group of new and current investors.
    Full story
  • IBM Brings V100 GPUs To Its Cloud

    Feb 2, 2018, 10:53 AM by Michael Croft
    TOP500 | The popularity of NVIDIA's Tesla V100 GPUs got another boost this week with IBM's announcement that it has added them to its cloud offerings.
    Full story
  • Adaptive Computing Enterprises Launches New Product for HPC Cloud Bursting

    Feb 2, 2018, 10:34 AM by Michael Croft
    NAPLES, FL, UNITED STATES - Feb 2, 2018 - Adaptive Computing announces its new Cloud Solution, Moab/NODUS Cloud Bursting, making HPC cloud strategies more accessible than ever before
    Full story
  • Certara Acquires BaseCase, A Life Sciences Data Visualization Company

    Feb 1, 2018, 11:30 AM by Michael Croft

    Bio-IT World Brief | Certara today announced that it has acquired BaseCase, a data visualization software as a service company who has extensive Health Economics and Outcomes Research expertise and is actively working in the area of market access.

    Full story
  • Atrius Health Leverages Linguamatics NLP to Support Value-Based Care

    Feb 1, 2018, 09:00 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Feb 1, 2018 -  Natural Language Processing (NLP) text analytics provider Linguamatics today announced the implementation of the Linguamatics Health enterprise NLP platform, powered by I2E, at Atrius Health to identify and extract critical clinical information hidden within unstructured patient data
    Full story
  • Susan Audino, Chair, Cannabis Advisory Panel and Chair, Cannabis Working Group at AOAC International, Joins the Scientific Advisory Board of CloudLIMS

    Feb 1, 2018, 04:27 AM by Michael Croft
    WILMINGTON, DE, US - Feb 1, 2018 - CloudLIMS, a Laboratory Information Management company specialized in offering data management solutions for cannabis testing laboratories, today announced that Dr
    Full story
  • New Knockout and Knockdown Validated Antibodies Are Launched by Creative Diagnostics for Bio-researchers

    Feb 1, 2018, 00:58 AM by Michael Croft
    SHIRLEY, NY - Feb 2, 2018 - As a leading supplier of high quality antibodies validated for use in multiplexed assays, Creative Diagnostics recently announces that it has added new Knockout and Knockdown Validated Antibodies to its existing antibodies portfolio, which are designed according to the scientific needs of global research institutes, universities and biotech and pharmaceutical companies, etc
    Full story
  • The Doctor Responsible For Gene Therapy’s Greatest Setback Is Sounding A New Alarm

    Jan 31, 2018, 14:49 PM by Michael Croft
    MIT Technology Review | Toxic effects seen in animals raise questions about new gene therapies for children.
    Full story
  • Equus Partners with HGST for High Density All-Flash Storage

    Jan 31, 2018, 11:55 AM by Michael Croft
    EDINA, MN, UNITED STATE OF AMERICA - Jan 31, 2018 - Equus Compute Solutions, the largest U.S. manufacturer of custom computer hardware systems to the channel, has partnered with HGST to offer their line of JBOF (Just a Bunch of Flash) All - Flash Storage systems
    Full story
  • Transpacific Biotech Startup Combines Asian Investors And Some Seriously Trendy Science Out Of MIT

    Jan 31, 2018, 10:53 AM by Michael Croft
    ENDPOINTS NEWS | Engine Biosciences plans to integrate AI and machine learning with hands-on lab work in drug development to create a whole new kind of drug development platform.
    Full story
  • Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry

    Jan 31, 2018, 09:21 AM by Michael Croft
    NEW YORK, NY - Jan 31, 2018 - Elsevier, the global information analytics business specializing in science and health, today announced that six start-up companies have been selected from more than 150 global applicants for The Hive, Elsevier's innovation initiative for biotech and pharmaceutical start-ups
    Full story
  • MR Solutions launches the most advanced Spectrometer for clinical MRI manufacturers

    Jan 31, 2018, 08:36 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Jan 31, 2018 - MR Solutions’ latest EVO2+ spectrometer now offers the most advanced levels of functionality and user control for constructors of clinical MRI scanners
    Full story
  • A Biopharma Innovator's Wish List For President Trump

    Jan 30, 2018, 15:47 PM by Michael Croft
    STAT | In his first State of the Union address, the CEO of Alnylam Pharmaceuticals would like to hear President Trump address five key issues to foster the culture of innovation in the pharmaceutical industry.
    Full story
  • Optibrium Expands US and UK Operations

    Jan 30, 2018, 07:08 AM by Michael Croft
    CAMBRIDGE, UK - Jan 30, 2018 - Optibrium, a developer of software for small molecule drug discovery, today announced it has appointed Dr
    Full story
  • Will America Yield Its Position As The World’s Leader In Science And Technology?

    Jan 29, 2018, 16:19 PM by Michael Croft
    BostonGlobe | For the first time since World War II, America's primacy in science and technology is in jeopardy. Choices that the country makes today will determine whether it continues to reap the rewards that come from being at the cutting edge.
    Full story
  • Oxford Nanopore MinION Used To Produce Most Complete Human Genome

    Jan 29, 2018, 12:45 PM by Michael Croft
    Bio-IT World   A paper published today in Nature Biotechnology, reports Oxford Nanopore sequencing resulting in the most complete human genome ever assembled with a single technology.
    Full story
  • Genedata, Congenica, Nanome, And More: News From January 2018

    Jan 29, 2018, 10:10 AM by Michael Croft

    Bio-IT World | January featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Genedata, Congenica, Nanome, and more.

    Full story
  • Video: The Hyve Discusses Health Data Research Infrastructures, IoT In Webinar

    Jan 26, 2018, 08:30 AM by Michael Croft

    Bio-IT World | In a recent webinar, Kees Bochove of The Hyve delved into consent, GDPR, the healthcare professional’s role in infrastructure, FAIR principles, open source solutions, the future of wearables, and much more.

    Full story
  • The Cult Of DNA-centricity

    Jan 25, 2018, 11:47 AM by Michael Croft
    Forbes | All of biology lies in the genome, right? That's a premise of modern medicine: a disease-free utopia based on gene therapy and, soon, gene editing. But what if the real answers lie in your proteins? DNA-centric thinking is holding back the next wave of cures for diseases like Alzheimer's.
    Full story
  • «
  • 301
  • 302
  • 303 (current)
  • 304
  • 305
  • 306
  • 307
  • 308
  • 309
  • 310
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy